Medication Considerations

This guide focuses on using medication-assisted treatment for opioid use disorder in jails and prisons and during the reentry process when justice-involved persons return to the community. 

This brief presents an overview of trends in substance use disorder treatment between 2015 and 2018 using data from two national surveys.

This report summarizes barriers and facilitators to providing MOUD at FQHCs and outlines opportunities at the health center, state, and federal level to support the clinical, organizational, and financial capacity to increase access to MOUD.

This case study explores implementation of a medications for opioid use disorder (MOUD) program at an organization in the Bronx, New York with a long history as an opioid treatment program (OTP) that also operates an FQHC and a certified community behavioral health clinic (CCBHC)

This case study explores implementation of medications for opioid use disorder (MOUD) through a federally qualified health center (FQHC) serving as a Health Care for the Homeless (HCH) program in Portland, Maine.

This case study explores implementation of medications for opioid use disorder (MOUD) at a federally qualified health center (FQHC) in rural California that engages with the broader community to address the opioid epidemic. 

This case study explores implementation of medications for opioid use disorder (MOUD) through a partnership between a Missouri-based federally qualified health center (FQHC) and Certified Community Behavioral Health Clinic (CCBHC).

This report provides an update on the present state of coverage, availability of, and access to, medications for treating ongoing alcohol use disorder and opioid use disorder, and reversing an opioid overdose within state Medicaid plans.

This Topic Brief provides an overview of what constitutes low-threshold treatment for patients with OUD, the state of the evidence and patient perspectives on low-threshold OUD treatment, and key steps and strategies for providing low-threshold treatment for patients with OUD in primary care settings.

This Topic Brief discusses perinatal behavioral health conditions, which include mental health and substance use disorders during pregnancy and the postpartum period (up to 12 months after delivery).